Literature DB >> 10344

Production of phospholipase C (alpha-toxin), haemolysins and lethal toxins by Clostridium perfringens types A to D.

R Möllby, T Holme, C E Nord, C J Smyth, T Wadström.   

Abstract

To obtain high yields of extracellular enzymes and toxins for immunological analysis, type culture collection strains of Clostridium perfringens types A to D and 28 fresh isolates of C. perfringens type A from humans were grown in fermenters under controlled conditions in a pre-reduced proteose peptone medium. The type culture collection strains all showed different characteristics with respect to growth rates and pH optima for growth. Production of phospholipase C (alpha-toxin), haemolysin and lethal activity varied considerably between the different types. Growth and extracellular protein production in fermenters with pH control and static or stirred cultures were compared. Production of all extracellular proteins measured was markedly improved by cultivation in fermenters with pH control. Strain ATCC13124 produced five times more phospholipase C than any of 28 freshly isolated strains of C. perfringens type A, grown under identical conditions. Haemolytic and lethal activities of the ATCC strain were equal or superior to the activities of any of the freshly isolated strains. There were no differences in the bacterial yields and in the production of extracellular toxins between type A strains isolated from clinical cases of gas gangrene and abdominal wounds, and those isolated from faecal samples from healthy persons.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10344     DOI: 10.1099/00221287-96-1-137

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  19 in total

Review 1.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

2.  Isolation and some properties of beta-hemolysin produced by Nocardia asteroides.

Authors:  A C Emeruwa
Journal:  Mycopathologia       Date:  1986-07       Impact factor: 2.574

3.  In vivo studies with two phospholipase C fractions from Pseudomonas aeruginosa.

Authors:  R S Berk; D Brown; I Coutinho; D Meyers
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

4.  Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens.

Authors:  Garry S A Myers; David A Rasko; Jackie K Cheung; Jacques Ravel; Rekha Seshadri; Robert T DeBoy; Qinghu Ren; John Varga; Milena M Awad; Lauren M Brinkac; Sean C Daugherty; Daniel H Haft; Robert J Dodson; Ramana Madupu; William C Nelson; M J Rosovitz; Steven A Sullivan; Hoda Khouri; George I Dimitrov; Kisha L Watkins; Stephanie Mulligan; Jonathan Benton; Diana Radune; Derek J Fisher; Helen S Atkins; Tom Hiscox; B Helen Jost; Stephen J Billington; J Glenn Songer; Bruce A McClane; Richard W Titball; Julian I Rood; Stephen B Melville; Ian T Paulsen
Journal:  Genome Res       Date:  2006-07-06       Impact factor: 9.043

Review 5.  Bacterial phospholipases C.

Authors:  R W Titball
Journal:  Microbiol Rev       Date:  1993-06

6.  Comparative genomics of VirR regulons in Clostridium perfringens strains.

Authors:  Antonio Frandi; Alessio Mengoni; Matteo Brilli
Journal:  BMC Microbiol       Date:  2010-02-25       Impact factor: 3.605

Review 7.  Clostridium perfringens in animal disease: a review of current knowledge.

Authors:  L Niilo
Journal:  Can Vet J       Date:  1980-05       Impact factor: 1.008

8.  Purification and characterization of an extracellular 29-kilodalton phospholipase C from Listeria monocytogenes.

Authors:  C Geoffroy; J Raveneau; J L Beretti; A Lecroisey; J A Vazquez-Boland; J E Alouf; P Berche
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

9.  Effect of antibiotics on toxin production and viability of Clostridium perfringens.

Authors:  D L Stevens; K A Maier; J E Mitten
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

10.  Role of alpha-toxin in Clostridium perfringens infection determined by using recombinants of C. perfringens and Bacillus subtilis.

Authors:  M Ninomiya; O Matsushita; J Minami; H Sakamoto; M Nakano; A Okabe
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.